Zhang Cheng, Zhang Lidan, Lyu Jian, Xie Yanming, Xie Yuting
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
School of Statistics, Renmin University of China, Beijing 100872, China.
Evid Based Complement Alternat Med. 2020 Nov 5;2020:3843752. doi: 10.1155/2020/3843752. eCollection 2020.
Our aim was to analyze the influence of Yinzhihuang granules on serum liver enzymes in jaundice patients and to provide real-world evidence for the efficacy evaluation of Yinzhihuang granules in treating jaundice.
We constructed a data warehouse which integrates real-world electronic medical records from the hospital information system of multiple 3A hospitals in China and used a descriptive statistical method to analyze the changes in the serum liver enzymes of the jaundice patients treated with Yinzhihuang granules and then used Wilcoxon signed-rank to test the changes in the indicators caused by the treatment.
After being treated with Yinzhihuang granules, the jaundice patients had a decrease in the average serum levels of total bilirubin, indirect bilirubin, aspartate aminotransferase, glutamyl transpeptidase, and alkaline phosphatase, and the differences were statistically significant ( < 0.05) but had no significant changes in the average serum levels of direct bilirubin and alanine aminotransferase ( > 0.05).
The data analysis on the real-world electronic medical records demonstrate that Yinzhihuang granules help to reduce jaundice patients' serum levels of total bilirubin, indirect bilirubin, aspartate aminotransferase, glutamyl transpeptidase, and alkaline phosphatase, but there is no evidence that Yinzhihuang granules help to reduce the jaundice patients' serum levels of direct bilirubin and alanine aminotransferase.
分析茵栀黄颗粒对黄疸患者血清肝酶的影响,为茵栀黄颗粒治疗黄疸的疗效评价提供真实世界证据。
构建数据仓库,整合中国多家三甲医院信息系统中的真实世界电子病历,采用描述性统计方法分析茵栀黄颗粒治疗黄疸患者血清肝酶的变化,然后用Wilcoxon符号秩检验治疗引起的指标变化。
茵栀黄颗粒治疗后,黄疸患者血清总胆红素、间接胆红素、天冬氨酸转氨酶、谷氨酰转肽酶和碱性磷酸酶的平均水平降低,差异有统计学意义(<0.05),但血清直接胆红素和丙氨酸转氨酶的平均水平无显著变化(>0.05)。
对真实世界电子病历的数据分析表明,茵栀黄颗粒有助于降低黄疸患者血清总胆红素、间接胆红素、天冬氨酸转氨酶、谷氨酰转肽酶和碱性磷酸酶水平,但没有证据表明茵栀黄颗粒有助于降低黄疸患者血清直接胆红素和丙氨酸转氨酶水平。